Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

7 mins

Michael Greenwood, AGS 2022: Femto, Aberrometry, and Multifocality in Glaucoma Patients: Where Do We Stand?

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 16th 2022

We are delighted to speak with Dr Michael Greenwood (Vance Thompson Vision, Fargo, ND) about his presentation on femtosecond lasers, aberrometry, and multifocality glaucoma patients and current research in these areas.

The presentation entitled ‘Femto, Aberrometry, and Multifocality in Glaucoma Patients: Where Do We Stand?’ was presented at the 2022 American Glaucoma Society Annual Meeting, March 03-06, 2022.

Questions:

  1. Your presentation covers multifocality in glaucoma patients, could you tell us a little about this? (00:19)
  2. What is the current status of research in these fields? (03:00)
  3. What are the key take-home messages of your presentation? (06:32)

Disclosures: Michael Greenwood is a consultant for Avellino, Equinox, Expert Opinion, Ivantis, Nevakar, New World Medical, Ocular Therapeutix, Tarsus.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.

Filmed in coverage of the virtual AGS 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup